Galectin ‐3 and ST2 as predictors of therapeutic success in high‐risk patients undergoing percutaneous mitral valve repair (MitraClip)

Clinical Cardiology,Volume 0, Issue ja, -Not available-.

Source: Clinical Cardiology - June 13, 2018 Category: Cardiology Authors: Oliver D örr MD , Claudia Walther MD , Christoph Liebetrau MD , Till Keller MD , Thomas Sommer MD , Niklas Boeder MD , Matthias Bayer MD , Pascal Bauer MD , Helge Möllmann MD , Luise Gaede MD , Christian Troidl Source Type: research